Capricor Therapeutics, Inc. SEC filings CAPR

Capricor Therapeutics, Inc. has 963 filings in SEC EDGAR's recent list, going back to Feb 7, 2001. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 24, 2026 (other events). The company's fiscal year ends on December 31.

Capricor Therapeutics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jan 30, 2026 —
424B5 Prospectus supplement Dec 5, 2025 —
424B3 Prospectus Dec 5, 2025 —
424B5 Prospectus supplement Dec 4, 2025 —
S-3 Shelf registration Sep 10, 2025 —
S-8 Employee stock plan registration Jun 16, 2025 —
S-8 Employee stock plan registration Feb 5, 2025 —
S-3 Shelf registration Oct 22, 2024 —
424B5 Prospectus supplement Oct 17, 2024 —
424B5 Prospectus supplement Oct 16, 2024 —
S-3/A Filing Oct 16, 2024 —
S-3 Shelf registration Jun 14, 2024 —
S-8 Employee stock plan registration Feb 16, 2024 —
424B5 Prospectus supplement Sep 29, 2023 —
FWP Free writing prospectus Sep 29, 2023 —
S-8 Employee stock plan registration Jan 31, 2023 —
S-8 Employee stock plan registration Feb 17, 2022 —
424B5 Prospectus supplement Jun 21, 2021 —
S-3/A Filing Jun 15, 2021 —
S-3 Shelf registration Mar 16, 2021 —
S-8 Employee stock plan registration Feb 12, 2021 —
S-8 Employee stock plan registration Jun 17, 2020 —
424B3 Prospectus May 19, 2020 —
S-3 Shelf registration May 7, 2020 —
424B5 Prospectus supplement May 4, 2020 —
424B4 Prospectus Dec 19, 2019 —
S-1/A Amended registration statement Dec 13, 2019 —
S-1/A Amended registration statement Dec 13, 2019 —
S-1 Registration statement Dec 5, 2019 —
424B5 Prospectus supplement Aug 29, 2019 —
424B5 Prospectus supplement Jul 22, 2019 —
S-3/A Filing Jul 17, 2019 —
S-3 Shelf registration Oct 24, 2018 —
424B5 Prospectus supplement Oct 19, 2017 —
424B3 Prospectus Jul 17, 2017 —
S-3 Shelf registration Jul 7, 2017 —
424B5 Prospectus supplement Apr 3, 2017 —
424B5 Prospectus supplement Mar 31, 2017 —
S-8 Employee stock plan registration Jan 11, 2017 —
424B5 Prospectus supplement Sep 16, 2016 —
424B5 Prospectus supplement Sep 16, 2016 —
424B5 Prospectus supplement Sep 15, 2016 —
424B3 Prospectus Jun 30, 2016 —
S-3 Shelf registration Jun 14, 2016 —
424B5 Prospectus supplement Mar 15, 2016 —
S-3 Shelf registration Sep 28, 2015 —
424B3 Prospectus Aug 10, 2015 —
POS AM Filing Jul 20, 2015 —
424B3 Prospectus Jun 12, 2015 —
POS AM Filing Jun 4, 2015 —
424B3 Prospectus Mar 30, 2015 —
S-1 Registration statement Mar 6, 2015 —
424B3 Prospectus Jun 6, 2014 —
S-1/A Amended registration statement May 23, 2014 —
S-1 Registration statement Apr 18, 2014 —
S-8 Employee stock plan registration Mar 4, 2014 —
424B3 Prospectus Aug 15, 2012 —
424B3 Prospectus May 16, 2012 —
424B3 Prospectus May 7, 2012 —
S-1 Registration statement Apr 25, 2012 —
424B5 Prospectus supplement Apr 2, 2012 —
424B3 Prospectus Nov 14, 2011 —
424B3 Prospectus Aug 15, 2011 —
424B3 Prospectus Aug 9, 2011 —
S-8 Employee stock plan registration Jul 22, 2011 —
S-1 Registration statement Jul 22, 2011 —
424B5 Prospectus supplement Apr 22, 2010 —
424B5 Prospectus supplement Apr 22, 2010 —
424B3 Prospectus Apr 12, 2010 —
424B3 Prospectus Apr 6, 2010 —
S-3 Shelf registration Mar 3, 2010 —
424B3 Prospectus Aug 27, 2009 —
S-3 Shelf registration Aug 13, 2009 —
S-8 Employee stock plan registration Jul 11, 2008 —
424B3 Prospectus Nov 15, 2007 —

Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CAPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1133869
Former names
Nile Therapeutics, Inc. (until Nov 20, 2013); SMI PRODUCTS INC (until Sep 19, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.